Nu Skin Enterprises (NYSE:NUS) Releases Q4 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its fourth quarter 2025 earnings guidance on Thursday. The company provided EPS guidance of 0.250-0.350 for the period, compared to the consensus EPS estimate of 0.330. The company issued revenue guidance of $365.0 million-$400.0 million, compared to the consensus revenue estimate of $392.1 million. Nu Skin Enterprises also updated its FY 2025 guidance to 1.250-1.350 EPS.

Nu Skin Enterprises Trading Down 2.0%

Shares of NYSE:NUS traded down $0.23 during mid-day trading on Thursday, reaching $10.87. 523,959 shares of the company were exchanged, compared to its average volume of 621,872. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.01 and a quick ratio of 1.38. The firm has a market cap of $537.80 million, a price-to-earnings ratio of 5.41 and a beta of 0.97. Nu Skin Enterprises has a 1 year low of $5.32 and a 1 year high of $14.62. The firm’s 50-day simple moving average is $11.44 and its 200 day simple moving average is $9.41.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.18. The company had revenue of $386.14 million for the quarter, compared to analyst estimates of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Equities research analysts forecast that Nu Skin Enterprises will post 1.05 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Nu Skin Enterprises in a report on Wednesday, October 8th. Zacks Research upgraded Nu Skin Enterprises to a “hold” rating in a research note on Tuesday, August 12th. Finally, Wall Street Zen upgraded Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 12th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $7.00.

Insider Activity

In other news, EVP Chayce David Clark sold 20,000 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total value of $239,400.00. Following the completion of the sale, the executive vice president directly owned 233,140 shares of the company’s stock, valued at $2,790,685.80. This represents a 7.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Laura Nathanson sold 6,489 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $12.22, for a total value of $79,295.58. Following the completion of the sale, the director directly owned 33,149 shares of the company’s stock, valued at $405,080.78. This represents a 16.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 58,926 shares of company stock valued at $711,364 in the last ninety days. 2.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On Nu Skin Enterprises

Several institutional investors have recently made changes to their positions in the business. Goldman Sachs Group Inc. raised its holdings in shares of Nu Skin Enterprises by 7.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company’s stock valued at $9,582,000 after purchasing an additional 88,088 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Nu Skin Enterprises by 9.3% during the second quarter. JPMorgan Chase & Co. now owns 764,052 shares of the company’s stock worth $6,105,000 after buying an additional 65,060 shares in the last quarter. AQR Capital Management LLC grew its holdings in Nu Skin Enterprises by 64.6% during the 1st quarter. AQR Capital Management LLC now owns 350,357 shares of the company’s stock valued at $2,530,000 after buying an additional 137,475 shares during the last quarter. BNP Paribas Financial Markets boosted its position in shares of Nu Skin Enterprises by 2.7% in the second quarter. BNP Paribas Financial Markets now owns 348,646 shares of the company’s stock worth $2,786,000 after acquiring an additional 9,052 shares during the last quarter. Finally, Man Group plc boosted its position in Nu Skin Enterprises by 209.6% during the 2nd quarter. Man Group plc now owns 247,992 shares of the company’s stock worth $1,981,000 after purchasing an additional 167,902 shares during the period. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.